REGN : REGENERON PHARMACEUTICALS stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-11-21 |
|---|---|---|---|---|
| 2025 | $766.36 | $766.36 | $766.36 | 1.38% |
| 2026 | $1040.31 | $900.85 | $1087.36 | 37.63% |
| 2027 | $1125.03 | $1041.13 | $1371.07 | 48.83% |
| 2028 | $1801.55 | $1426.86 | $1952.46 | 138.33% |
| 2029 | $1639.31 | $1396.15 | $1896.46 | 116.87% |
| 2030 | $1375.34 | $1329.48 | $1409.92 | 81.95% |
| 2031 | $1752.08 | $1374.07 | $2320.0 | 131.79% |
| 2032 | $1931.85 | $1556.96 | $2194.43 | 155.57% |
| 2033 | $1371.61 | $1300.2 | $1505.4 | 81.45% |
| 2034 | $1727.72 | $1366.99 | $2089.71 | 128.56% |
| 2035 | $2055.48 | $1812.28 | $2220.62 | 171.92% |
The 13 Wall Street analysts offering REGENERON PHARMACEUTICALS stock forecast in the last 6 months have average price target of
$753.46 with a high forecast of $865.0 and a low forecast of $615.0.
The average REGENERON PHARMACEUTICALS stock forecast represents a -0.32%
decrease from the last price of $755.900024414062.
For REGENERON PHARMACEUTICALS stock forecast for 2025, 1 predictions are offered for each month of 2025 with average REGENERON PHARMACEUTICALS stock
forecast of $766.36, a high forecast of $766.36, and a low forecast of $766.36.
The average REGENERON PHARMACEUTICALS stock forecast 2025 represents a 1.38%
increase from the last price of $755.900024414062.
For REGENERON PHARMACEUTICALS stock forecast for 2026, 12 predictions are offered for each month of 2026 with average REGENERON PHARMACEUTICALS stock
forecast of $1040.31, a high forecast of $1087.36, and a low forecast of $900.85.
The average REGENERON PHARMACEUTICALS stock forecast 2026 represents a 37.63%
increase from the last price of $755.900024414062.
For REGENERON PHARMACEUTICALS stock forecast for 2028, 12 predictions are offered for each month of 2028 with average REGENERON PHARMACEUTICALS stock
forecast of $1801.55, a high forecast of $1952.46, and a low forecast of $1426.86.
The average REGENERON PHARMACEUTICALS stock forecast 2028 represents a 138.33%
increase from the last price of $755.900024414062.
For REGENERON PHARMACEUTICALS stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average REGENERON PHARMACEUTICALS stock
forecast of $1375.34, a high forecast of $1409.92, and a low forecast of $1329.48.
The average REGENERON PHARMACEUTICALS stock forecast 2030 represents a 81.95%
increase from the last price of $755.900024414062.
For REGENERON PHARMACEUTICALS stock forecast 2031, 12 predictions are offered for each month of 2031 with average REGENERON PHARMACEUTICALS stock
forecast of $1752.08, a high forecast of $2320.0, and a low forecast of $1374.07.
The average REGENERON PHARMACEUTICALS stock forecast 2031 represents a 131.79%
increase from the last price of $755.900024414062.
For REGENERON PHARMACEUTICALS stock forecast for 2035 (10 year), 11 predictions are offered for each month of 2035 with average REGENERON PHARMACEUTICALS stock
forecast of $2055.48, a high forecast of $2220.62, and a low forecast of $1812.28.
The average REGENERON PHARMACEUTICALS stock forecast 2035 represents a 171.92%
increase from the last price of $755.900024414062.
Please, see more forecasts below.
REGN : REGENERON PHARMACEUTICALS stock forecast by Wall Street Analysts
The average REGENERON PHARMACEUTICALS stock forecast from last 6 month is $753.46, and this show a 2.06% increase in average from the prior price target of the each prediction. Also, this average forecast of $753.46 represents a -3.59% decrease from the past average forecast of $781.54, 6 months ago from 35 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-10-29 | B of A Securities | $543.0000 | $627.0000 | Underperform |
| 2025-10-29 | Guggenheim | $815.00 | $865.0000 | Buy |
| 2025-10-29 | Cantor Fitzgerald | $678.0000 | $740.0000 | Overweight |
| 2025-10-29 | Wells Fargo | $580.0000 | $615.0000 | Equal-Weight |
| 2025-10-29 | RBC Capital | $704.0000 | $708.0000 | Sector Perform |
| 2025-10-29 | Citigroup | $660.00 | $700.0000 | Buy |
| 2025-10-23 | Canaccord Genuity | $850.0000 | $850 | Buy |
| 2025-10-14 | Canaccord Genuity | $850.00 | $850.00 | Buy |
| 2025-10-13 | Citigroup | $650.00 | $660.0000 | Buy |
| 2025-10-10 | Morgan Stanley | $761.00 | $756.0000 | Overweight |
| 2025-08-27 | Jefferies | $813.0000 | $831 | Buy |
| 2025-08-27 | Bernstein | $753.0000 | $781.0000 | Outperform |
| 2025-08-11 | Truist Securities | $940.00 | $812 | Buy |
| 2025-08-04 | Guggenheim | $810.0000 | $815.0000 | Buy |
| 2025-08-04 | RBC Capital | $688.0000 | $695.0000 | Sector Perform |
| 2025-08-04 | Morgan Stanley | $754.00 | $761 | Overweight |
| 2025-08-04 | BMO Capital | $600.00 | $640 | Outperform |
| 2025-07-23 | Canaccord Genuity | $850.00 | $850.00 | Buy |
| 2025-07-11 | UBS | $560.00 | $584.0000 | Neutral |
| 2025-07-10 | Morgan Stanley | $755.0000 | $754 | Overweight |
| 2025-06-09 | JP Morgan | $950.0000 | $800.0000 | Overweight |
| 2025-06-05 | UBS | $633.00 | $560.0000 | Neutral |
| 2025-06-02 | Morgan Stanley | $958.0000 | $755.0000 | Overweight |
| 2025-06-02 | Citigroup | $700.00 | $650.0000 | Buy |
| 2025-06-02 | BMO Capital | $800.00 | $600 | Outperform |
| 2025-05-30 | Wells Fargo | $700.00 | $580.0000 | Equal-Weight |
| 2025-05-27 | RBC Capital | $943.0000 | $943 | Outperform |
| 2025-05-14 | Citigroup | $600.0000 | $700.0000 | Buy |
| 2025-05-05 | Morgan Stanley | $1081.0000 | $958.0000 | Overweight |
| 2025-05-01 | Guggenheim | $940.0000 | $810.0000 | Buy |
| 2025-04-30 | Baird | $652.00 | $587 | Neutral |
| 2025-04-30 | Truist Securities | $975.00 | $940 | Buy |
| 2025-04-30 | Goldman Sachs | $917.00 | $804 | Buy |
| 2025-04-30 | RBC Capital | $1051.0000 | $943.0000 | Outperform |
| 2025-04-30 | Wells Fargo | $750.0000 | $700.0000 | Overweight |
| 2025-04-30 | BMO Capital | $865.0000 | $800 | Outperform |
| 2025-04-30 | UBS | $768.0000 | $633.0000 | Neutral |
| 2025-04-30 | JP Morgan | $1000.00 | $950.0000 | Overweight |
| 2025-04-29 | Oppenheimer | $925.00 | $900 | Outperform |
| 2025-04-25 | Baird | $759.00 | $652 | Neutral |
| 2025-04-23 | Truist Securities | $1004.00 | $975 | Buy |
| 2025-04-22 | Cantor Fitzgerald | $695.0000 | Overweight | |
| 2025-04-22 | Canaccord Genuity | $1152.0000 | $850.0000 | Buy |
| 2025-04-17 | B of A Securities | $575.0000 | $547 | Underperform |
| 2025-04-14 | Goldman Sachs | $1019.0000 | $917 | Buy |
| 2025-04-09 | Morgan Stanley | $1150.0000 | $1081 | Overweight |
| 2025-04-03 | Oppenheimer | $950.00 | $925 | Outperform |
| 2025-03-31 | JP Morgan | $1100.0000 | $1000.0000 | Overweight |
REGENERON PHARMACEUTICALS stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-11-24 | $764.58 | 1.15% |
| 2025-11-25 | $770.92 | 0.83% |
| 2025-11-26 | $772.27 | 0.18% |
| 2025-11-28 | $771.18 | -0.14% |
| 2025-12-01 | $783.18 | 1.56% |
REGN : Long term REGENERON PHARMACEUTICALS stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 Dec. is $766.36 , for 2026 Nov. is $1033.64 , for 2029 Nov. is $1421.15 , for 2030 Nov. is $1375.53 , for 2034 Nov. is $2071.17 , and for 2035 Nov. is $1812.28.
REGN : REGENERON PHARMACEUTICALS stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Dec. | $766.36 | 1.38% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $900.85 | 17.55% |
| 2026 Feb. | $1022.00 | 13.45% |
| 2026 Mar. | $1076.22 | 5.31% |
| 2026 Apr. | $1087.36 | 1.03% |
| 2026 May. | $1082.24 | -0.47% |
| 2026 Jun. | $1070.20 | -1.11% |
| 2026 Jul. | $1056.12 | -1.32% |
| 2026 Aug. | $1046.11 | -0.95% |
| 2026 Sep. | $1039.23 | -0.66% |
| 2026 Oct. | $1035.58 | -0.35% |
| 2026 Nov. | $1033.64 | -0.19% |
| 2026 Dec. | $1034.23 | 0.06% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $1041.13 | 0.67% |
| 2027 Feb. | $1051.20 | 0.97% |
| 2027 Mar. | $1046.35 | -0.46% |
| 2027 Apr. | $1062.17 | 1.51% |
| 2027 May. | $1056.99 | -0.49% |
| 2027 Jun. | $1052.85 | -0.39% |
| 2027 Jul. | $1046.69 | -0.58% |
| 2027 Aug. | $1097.00 | 4.81% |
| 2027 Sep. | $1160.32 | 5.77% |
| 2027 Oct. | $1213.67 | 4.60% |
| 2027 Nov. | $1300.94 | 7.19% |
| 2027 Dec. | $1371.07 | 5.39% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $1426.86 | 4.07% |
| 2028 Feb. | $1485.27 | 4.09% |
| 2028 Mar. | $1570.31 | 5.73% |
| 2028 Apr. | $1722.09 | 9.67% |
| 2028 May. | $1930.46 | 12.10% |
| 2028 Jun. | $1952.46 | 1.14% |
| 2028 Jul. | $1942.81 | -0.49% |
| 2028 Aug. | $1933.61 | -0.47% |
| 2028 Sep. | $1925.04 | -0.44% |
| 2028 Oct. | $1917.09 | -0.41% |
| 2028 Nov. | $1909.72 | -0.38% |
| 2028 Dec. | $1902.87 | -0.36% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $1896.46 | -0.34% |
| 2029 Feb. | $1890.46 | -0.32% |
| 2029 Mar. | $1875.05 | -0.82% |
| 2029 Apr. | $1819.78 | -2.95% |
| 2029 May. | $1721.12 | -5.42% |
| 2029 Jun. | $1639.54 | -4.74% |
| 2029 Jul. | $1571.38 | -4.16% |
| 2029 Aug. | $1516.72 | -3.48% |
| 2029 Sep. | $1476.80 | -2.63% |
| 2029 Oct. | $1447.11 | -2.01% |
| 2029 Nov. | $1421.15 | -1.79% |
| 2029 Dec. | $1396.15 | -1.76% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $1371.06 | -1.80% |
| 2030 Feb. | $1346.08 | -1.82% |
| 2030 Mar. | $1329.48 | -1.23% |
| 2030 Apr. | $1409.92 | 6.05% |
| 2030 May. | $1396.04 | -0.98% |
| 2030 Jun. | $1387.08 | -0.64% |
| 2030 Jul. | $1381.77 | -0.38% |
| 2030 Aug. | $1378.81 | -0.21% |
| 2030 Sep. | $1377.16 | -0.12% |
| 2030 Oct. | $1376.19 | -0.07% |
| 2030 Nov. | $1375.53 | -0.05% |
| 2030 Dec. | $1374.99 | -0.04% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $1374.51 | -0.03% |
| 2031 Feb. | $1374.07 | -0.03% |
| 2031 Mar. | $1376.49 | 0.18% |
| 2031 Apr. | $1382.56 | 0.44% |
| 2031 May. | $1394.05 | 0.83% |
| 2031 Jun. | $1556.41 | 11.65% |
| 2031 Jul. | $1768.09 | 13.60% |
| 2031 Aug. | $1926.73 | 8.97% |
| 2031 Sep. | $2021.42 | 4.91% |
| 2031 Oct. | $2320.00 | 14.77% |
| 2031 Nov. | $2287.86 | -1.39% |
| 2031 Dec. | $2242.76 | -1.97% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $2194.43 | -2.15% |
| 2032 Feb. | $2148.47 | -2.09% |
| 2032 Mar. | $2107.63 | -1.90% |
| 2032 Apr. | $2072.41 | -1.67% |
| 2032 May. | $2041.84 | -1.48% |
| 2032 Jun. | $2014.32 | -1.35% |
| 2032 Jul. | $1988.30 | -1.29% |
| 2032 Aug. | $1917.67 | -3.55% |
| 2032 Sep. | $1806.64 | -5.79% |
| 2032 Oct. | $1708.93 | -5.41% |
| 2032 Nov. | $1624.59 | -4.94% |
| 2032 Dec. | $1556.96 | -4.16% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $1505.40 | -3.31% |
| 2033 Feb. | $1464.63 | -2.71% |
| 2033 Mar. | $1428.96 | -2.44% |
| 2033 Apr. | $1395.46 | -2.34% |
| 2033 May. | $1364.62 | -2.21% |
| 2033 Jun. | $1338.77 | -1.89% |
| 2033 Jul. | $1319.78 | -1.42% |
| 2033 Aug. | $1307.82 | -0.91% |
| 2033 Sep. | $1301.60 | -0.48% |
| 2033 Oct. | $1300.20 | -0.11% |
| 2033 Nov. | $1361.73 | 4.73% |
| 2033 Dec. | $1370.39 | 0.64% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $1368.60 | -0.13% |
| 2034 Feb. | $1367.61 | -0.07% |
| 2034 Mar. | $1366.99 | -0.05% |
| 2034 Apr. | $1372.75 | 0.42% |
| 2034 May. | $1435.29 | 4.56% |
| 2034 Jun. | $1648.52 | 14.86% |
| 2034 Jul. | $1870.28 | 13.45% |
| 2034 Aug. | $2017.15 | 7.85% |
| 2034 Sep. | $2081.17 | 3.17% |
| 2034 Oct. | $2089.71 | 0.41% |
| 2034 Nov. | $2071.17 | -0.89% |
| 2034 Dec. | $2043.40 | -1.34% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $2014.95 | -1.39% |
| 2035 Feb. | $2220.62 | 10.21% |
| 2035 Mar. | $2178.47 | -1.90% |
| 2035 Apr. | $2142.64 | -1.64% |
| 2035 May. | $2112.14 | -1.42% |
| 2035 Jun. | $2085.41 | -1.27% |
| 2035 Jul. | $2060.84 | -1.18% |
| 2035 Aug. | $2037.06 | -1.15% |
| 2035 Sep. | $2013.15 | -1.17% |
| 2035 Oct. | $1932.71 | -4.00% |
| 2035 Nov. | $1812.28 | -6.23% |
Financial Data for REGENERON PHARMACEUTICALS stock
Frequently Asked Questions about REGENERON PHARMACEUTICALS stock forecast
Is REGENERON PHARMACEUTICALS a good long term stock?
From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2025 Dec. is $766.355633329141 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2026 Nov. is $1033.64396937346 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2029 Nov. is $1421.14655122754 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2030 Nov. is $1375.52510351631 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2034 Nov. is $2071.16629711059 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2035 Nov. is $1812.27917101295
Is REGENERON PHARMACEUTICALS stock overvalued?
REGENERON PHARMACEUTICALS (REGN) stock is expected to go UP . Therefore, AIPickup would say that REGENERON PHARMACEUTICALS (REGN) stock is NOT overvalued.
Will REGENERON PHARMACEUTICALS stock price go up?
Yes. The REGENERON PHARMACEUTICALS stock price forecast for 2026 Nov. is $1033.64396937346
Is REGENERON PHARMACEUTICALS stock a good buy now?
Since closing price on 2025-11-21 is $755.900024414062 and forecast for 2026 Nov. is $1033.64, REGENERON PHARMACEUTICALS stock is a good 1 year investment.
14 Days Historical Data for REGENERON PHARMACEUTICALS stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| REGN stock price for 2025-11-04 | $627.21 | $642.97 | $624.36 | $645.41 |
| REGN stock price for 2025-11-05 | $643.38 | $630.31 | $627.21 | $646.08 |
| REGN stock price for 2025-11-06 | $646.06 | $640.03 | $640.03 | $656.18 |
| REGN stock price for 2025-11-07 | $656.71 | $649.54 | $640.19 | $657.39 |
| REGN stock price for 2025-11-10 | $653.92 | $655.18 | $652.37 | $665.16 |
| REGN stock price for 2025-11-11 | $673.71 | $650.66 | $650.56 | $675.48 |
| REGN stock price for 2025-11-12 | $680.87 | $678.04 | $671.83 | $689.91 |
| REGN stock price for 2025-11-13 | $694.12 | $682.14 | $679.08 | $712.69 |
| REGN stock price for 2025-11-14 | $692.63 | $696.32 | $685.09 | $698.39 |
| REGN stock price for 2025-11-17 | $703.43 | $692.47 | $691.42 | $710.99 |
| REGN stock price for 2025-11-18 | $724.43 | $701.63 | $698.34 | $727.06 |
| REGN stock price for 2025-11-19 | $701.87 | $726.90 | $701.75 | $726.90 |
| REGN stock price for 2025-11-20 | $737.00 | $725.00 | $720.02 | $753.51 |
| REGN stock price for 2025-11-21 | $755.90 | $736.01 | $735.74 | $764.09 |